M84.553 Pathological fracture in neoplastic disease, unspecified femur

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Unspecified Femur (ICD-10-CM: M84.553)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the femur. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the integrity of the femur, which may involve primary bone tumors or metastatic spread to this skeletal region.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the femur, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode the femur, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the femur.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to femoral sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often severe and unexplained by trauma.
• Swelling, bruising, or deformity around the femur.
• Difficulty bearing weight or moving the affected leg.
• Limited range of motion in the hip or knee.
• Possible signs of underlying cancer (e.g., weight loss, fatigue) if not previously diagnosed.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A thorough history and physical exam assess pain, mobility, and signs of malignancy. Imaging studies, such as X-rays, CT scans, or MRI, visualize the fracture and detect bone lesions or metastasis. Biopsy of the affected bone or primary tumor may confirm the neoplastic cause. Blood tests (e.g., calcium, alkaline phosphatase) and imaging of other sites evaluate cancer spread.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Orthopedic interventions (e.g., casting, internal fixation, or prosthetic replacement) restore skeletal integrity. Oncologic therapies (surgery, chemotherapy, radiation) target the primary or metastatic disease. Pain management, physical therapy, and supportive care (e.g., bisphosphonates to strengthen bone) are often included. Multidisciplinary care coordinates orthopedic and oncologic specialists.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, fracture severity, and treatment response. Early intervention improves outcomes, but metastatic disease may limit recovery. Follow-up includes regular imaging to monitor healing and cancer progression, pain assessments, and functional evaluations. Long-term surveillance for recurrent fractures or treatment-related complications (e.g., infection, hardware failure) is essential.

Complications

• Delayed or nonunion of the fracture due to compromised bone healing.
• Infection at the fracture site or from surgical intervention.
• Nerve damage or vascular injury affecting leg function.
• Metastatic spread of cancer to other bones or organs.
• Adverse effects from cancer treatments (e.g., chemotherapy-induced neuropathy).

Lifestyle & Prevention

• Maintain bone health through adequate calcium, vitamin D, and weight-bearing exercise (if appropriate).
• Avoid high-impact activities that risk falls or injury.
• Follow oncologic treatment plans to control cancer and reduce bone destruction.
• Use assistive devices (e.g., crutches, walkers) to protect the femur during healing.
• Attend regular screenings for cancer recurrence or new metastases.

When to Seek Professional Help

Seek immediate medical attention for sudden, severe leg pain, inability to bear weight, or visible deformity. Prompt evaluation is critical to confirm the fracture and initiate treatment. Contact a healthcare provider if pain worsens, swelling increases, or new symptoms (e.g., fever, unexplained weight loss) develop, as these may indicate infection or cancer progression.

Tips for Medical Coders

Code M84.553 is specific to a pathological fracture in neoplastic disease of the unspecified femur. Document the fracture site (unspecified femur) and confirm the underlying neoplastic cause. Ensure the record links the fracture to the cancer diagnosis (primary or metastatic) and includes details on treatment or complications. Avoid using this code for traumatic fractures without neoplastic involvement. Verify laterality (e.g., right/left femur) if specified, as separate codes exist for those scenarios.